Blue Trust’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.18K Buy
+16
New +$2.28K ﹤0.01% 2027

Other funds holding PTGX

Blue Trust's PTGX Position: Q3 2026 in Review

Blue Trust opened a new position in Protagonist Therapeutics (PTGX) in Q3 2026: 16 shares worth $2.18K. The stake represents ﹤0.01% of the portfolio and ranks #2027 among its holdings.

310 funds tracked by Wall St. Rank hold PTGX as of Q3 2026.

  • Blue Trust held 16 shares of Protagonist Therapeutics worth $2.18K as of Q3 2026.
  • Protagonist Therapeutics was a new Blue Trust position in Q3 2026.
  • Protagonist Therapeutics made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2027 holding.
  • 310 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.